Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $32.01 USD
Change Today -0.25 / -0.77%
Volume 476.0K
ACOR On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Enrique J. Carrazana M.D.

Chief Medical Officer, Acorda Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 2 different industries.

See Board Relationships
52$1,663,699
As of Fiscal Year 2014

Background*

Dr. Enrique J. Carrazana, M.D. has been the Chief Medical Officer of Acorda Therapeutics, Inc., since October 2011. Dr. Carrazana is a Board-certified neurologist with over 20 years of experience in the pharmaceutical industry and clinical practice. Most recently, from October 2010 to September 2011, Dr. Carrazana served as Director of the Epilepsy Center of Excellence at the Miami Veterans’ Administration (VA) Hospital and Associate Professor of Neurology at the University ...

Read Full Background

Corporate Headquarters*

420 Saw Mill River Road
Ardsley, New York 10502

United States

Phone: 914-347-4300
Fax: 914-347-4560

Board Members Memberships*

2013-Present
Director and Member of Compensation Committee

Education*

MD
Harvard Medical School

Other Affiliations*

Annual Compensation*

Salary$434,000
Total Annual Compensation$434,000

Stock Options*

Restricted Stock Awards$259,908
All Other Compensation$18,677
Exercisable Options100,546
Unexercisable Options83,189
Total Number of Options183,735

Total Compensation*

Total Annual Cash Compensation$684,028
Total Short Term Compensation$434,000
Other Long Term Compensation$278,585
Total Calculated Compensation$1,663,699
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACOR:US $32.01 USD -0.25

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$470.4K
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Inc.
$1.4M
Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Isis Pharmaceuticals, Inc.
$1.5M
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$620.1K
Stephen R. Davis J.D.Interim Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Executive Vice President
ACADIA Pharmaceuticals Inc.
$245.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACORDA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.